PMID: 4903622Sep 1, 1969Paper

Peritoneal infections in patients on long-term peritoneal dialysis before and after human cadaveric renal transplantation

Journal of Clinical Pathology
D A Leigh

Abstract

Long-term peritoneal dialysis was carried out on 38 patients awaiting human cadaveric renal transplantation. Fifty-eight per cent of patients developed infection before transplantation and 41% of those requiring dialysis after transplantation became infected. Infection did not usually occur before the third day of dialysis and 26% of patients developed their first episode of infection in the first week. Almost 50% of patients had only a single episode of infection. The overall rate of infection per 100 patient days of dialysis was 1.23 before transplantation and 4.17 after transplantation. The commonest infecting organisms were Staph aureus and Staph albus and these organisms were frequently isolated from the skin around the dialysis catheter before the infection occurred. Gram-negative infections were more commonly seen after transplantation.Sixty-five per cent of the infections responded to a single course of antibiotic therapy administered in the dialysis fluid. After transplantation Gram-negative infections were usually associated with severe complications and were a major cause of death. Peritoneal dialysis is a convenient way of maintaining patients with chronic renal failure before human cadaveric renal transplantation, ...Continue Reading

References

Feb 17, 1968·British Medical Journal·S L Cohen, A Percival
Jan 1, 1968·Medicine·J Z MontgomerieL B Guze
Apr 1, 1966·The Journal of Pathology and Bacteriology·R R Gillies, J R Govan
Nov 1, 1966·The American Journal of the Medical Sciences·S RibotA Bernstein
Jan 9, 1967·JAMA : the Journal of the American Medical Association·F D SchwartzR M Kark
Jun 20, 1959·Journal of the American Medical Association·M H MAXWELLM R TWISS
Nov 22, 1962·The New England Journal of Medicine·R O BURNSJ P MERRILL
Apr 11, 1964·British Medical Journal·W B THOMSONW S PEART
Jun 1, 1965·The Journal of Obstetrics and Gynaecology of the British Commonwealth·J D WILLIAMSM C PATH
May 11, 1950·The New England Journal of Medicine·F B SCHWEINBURGJ FINE
Jul 1, 1950·The American Journal of Medicine·H M ODELM H POWER

❮ Previous
Next ❯

Citations

Dec 1, 1994·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J A PalmerH J Baluarte
Jul 15, 1982·Klinische Wochenschrift·A von Graevenitz
Feb 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C Chenoweth, D Schaberg
Aug 1, 1990·Annals of Surgery·P S BarieJ P Waymack
Jan 1, 1977·Archives of Disease in Childhood·R E Day, R H White
Jul 1, 1978·Archives of Disease in Childhood·V P Choudhry
May 1, 1971·Journal of Clinical Pathology·D A Leigh
Jan 1, 1979·Scandinavian Journal of Infectious Diseases·H J Kolmos, K E Hemmeløff Andersen
Sep 1, 1987·The American Journal of the Medical Sciences·J RubinJ D Bower
Mar 1, 1983·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R Rault
May 1, 1984·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D SteinmullerS Nakamoto
Sep 1, 1986·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H E LeichterR N Fine
Jan 1, 1978·Journal of Chronic Diseases·J T Mader, J A Reinarz
Sep 1, 1984·American Journal of Surgery·S H Dougherty
Jan 1, 1986·Tropical Doctor·R JeyarajahB D Dharmasena
Jan 1, 1990·Clinical Microbiology Reviews·B E Murray
Apr 1, 1987·Kidney International·M Malagon, R J Hogg

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

British Medical Journal
D G Oreopoulos, S Izatt
Journal of Pharmaceutical Sciences
A M Mattocks, E A el-Bassiouni
Antimicrobial Agents and Chemotherapy
A J Weinstein, R C Moellering
© 2021 Meta ULC. All rights reserved